Assistance Publique - Hôpitaux de Paris
Paris, 75019, France
NCT Number: NCT01679925
GnRH agonists are used in the treatment of precocious puberty in order to improve adult height.However,the psychosocial impact of precocious puberty is often used by the clinician at diagnosis to justify treatment, but can not yet be properly assessed. It can not be considered as a rational neither for the indication to treatment, nor to assess its potential efficacy.
The overall objective of this work is to improve the conditions leading to the therapeutic decision and the procedures for monitoring girls with idiopathic central precocious puberty.
Looking for future studies?
Notify Me6 year–8 year
Female
Observational
Paris, 75019, France
During the day hospital, the diagnostic workup for precocious puberty will be performed and include:
These reviews are conducted as part of usual care and are required to validate the inclusion criteria of patients.
The CBCL questionnaire will be completed by patient's parents and the first semi-structured interview will be conducted by a sociologist assisted by the psychologist, dedicated to the study.
Patient's follow-up will be planned 6 months after inclusion, including similar investigations (except MRI).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 day
Time frame: 1 day
Quantitative data on the psychosocial status of patients will be collected as a self-administered questionnaire: the Child Behavior Checklist (CBCL) that is validated.
Time frame: 6 months
Changing views of qualitative and quantitative data will be followed six months after the diagnosis of precocious puberty, with or without treatment.
Assistance Publique - Hôpitaux de Paris
Other
Qualitative Assessment of the Psychosocial Impact of Early Puberty in Girls Aged 6 to 8 Years
Acronym: PUPSY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04317014
Early Puberty, Endocrine System Diseases
View Trial DetailsNCT05493709
Endocrine System Diseases, Gonadal Disorders
Tucson, Arizona, United States
View Trial DetailsNCT07359092
Central Precocious Puberty (CPP), Endocrine System Diseases
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT05341128
Central Precocious Puberty, Endocrine System Diseases
Nanning, Guangxi, China
View Trial Details